Blood clotting and COVID-19: a growing concern
Early on researchers had observed the complications of abnormal blood clotting in COVID-19 patients. D Dimer, a coagulation marker, is playing an important role in early identification of complications caused due to blood clotting and thus aiding in treatment of severe COVID-19 cases. How blood clots are proving to be fatal in COVID-19 Early on, while doctors were still trying to understand COVID-19, signs of blood clotting were being detected in different organs. Nephorologists were noticing dialysis catheters getting plugged with clots. Neurosurgeons were witnessing a surge in patients with strokes. “Researchers have found stroke rate to be seven times higher in patients with severe COVID-19 than those with severe seasonal flu(1).” Evolving clinical resources confirm a convoluted role of abnormal blood clotting in COVID-19 that manifests in the form of both micro thrombosis (formation of small blood clots) and venous thromboembolism (VTE). VTE is a condition when a ...